Background
Coagulopathy is associated with massive transfusion (MT) in trauma, yet most clinical scores to predict this outcome do not incorporate coagulation assays. Previous work has identified that shock increases circulating tissue plasminogen activator(tPA). When tPA levels saturate endogenous inhibitors, systemic hyperfibrinolysis can occur. Therefore, the addition of tPA to a patient’s blood sample could stratify a patients underlying degree of shock and early coagulation changes to predict progression to MT. We hypothesize that a modified thrombelastography (TEG) assay with exogenous tPA, will unmask patients impending risk of MT.
Study Design
Trauma activations were analyzed using rapid TEG(R-TEG) and a modified TEG assay wuth low (Lt-TEG) and high dose of tPA(Ht-TEG). Clinical scores(Shock Index [SI], ABC, and TASH,) were compared to TEG measurements to predict the need for MT, using the areas under the receiver operating characteristic curves.
Results
324 patients were analyzed, 17% required MT. MT patients had a median SI=1.2, ABC score=1, and TASH score=12. R-TEG and tPA TEG parameters were different significantly different in all MT patients compared to non-MT patients (all p<0.02). The Lt-LY30 (lysis at 30 minutes) had the largest AUROC (0.86, 95%CI 0.79–0.93) for prediction of MT similar to INR0.86 (95%CI 0.81–0.91) followed by TASH (0.83, (95%CI 0.77–0.89). Combing INR and tPA-TEG variables results in a positive prediction of MT in 49% of patients with a 98% negative predictive value.
Conclusion
tPA-TEG identifies trauma patients who require MT efficiently, in a single assay that can be completed in a shorter time than other scoring systems, which has improved performance when combined with INR. This new method is consistent with our understanding of the molecular events responsible for trauma-induced coagulopathy.